963313

HQ Specialty Pharma — FEI 3011850338

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 15, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Paramus, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)